RXRA and neoplasm: The RXRα agonist berberine promotes KRT7-AS expression and increases PTEN levels, activates the tumor suppressive RXRα-KRT7-AS-PTEN axis, inhibits tumorigenic AKT and NF-κB signaling pathways, tumorigenesis, and promotes apoptosis.